三阴性乳腺癌的潜在治疗靶点。 - Suppr

Suppr

超能文献

Potential therapeutic target for triple-negative breast cancer.

作者信息

Gilbert Judith A

出版信息

Lancet Oncol. 2012 Aug;13(8):e330. doi: 10.1016/s1470-2045(12)70298-x.

DOI:10.1016/s1470-2045(12)70298-x

PMID:23024992

Abstract

摘要

相似文献

Potential therapeutic target for triple-negative breast cancer.

Lancet Oncol. 2012 Aug;13(8):e330. doi: 10.1016/s1470-2045(12)70298-x.

Ribociclib in HR-positive, HER2-negative breast cancer.

Lancet Oncol. 2016 Nov;17(11):e482. doi: 10.1016/S1470-2045(16)30502-2. Epub 2016 Oct 13.

Breast density influences tumor subtypes and tumor aggressiveness.

J Natl Cancer Inst. 2011 Aug 3;103(15):1143-5. doi: 10.1093/jnci/djr263. Epub 2011 Jul 27.

Are triple-negative tumours and basal-like breast cancer synonymous?

Breast Cancer Res. 2007;9(6):404; author reply 405. doi: 10.1186/bcr1827.

Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows.

J Clin Oncol. 2019 Apr 10;37(11):862-866. doi: 10.1200/JCO.18.02433. Epub 2019 Feb 27.

What is the value of the 21 gene recurrence score in HER2-negative patients?

J Clin Oncol. 2010 Nov 1;28(31):e647; author reply e648. doi: 10.1200/JCO.2010.31.2280. Epub 2010 Sep 27.

Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy.

J BUON. 2013 Jan-Mar;18(1):289.

Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?

Hum Pathol. 2017 Apr;62:215-221. doi: 10.1016/j.humpath.2016.12.019. Epub 2016 Dec 30.

Measurement of erbB-2 oncoprotein in human breast cancers by ELISA.

Biochem Soc Trans. 1992 Feb;20(1):82S. doi: 10.1042/bst020082s.

[Modern pharmacological therapy of breast cancer].

Orv Hetil. 2012 Jan 15;153(2):56-65. doi: 10.1556/OH.2012.29257.

引用本文的文献

Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.

Mol Oncol. 2016 Jun;10(6):775-88. doi: 10.1016/j.molonc.2016.01.002. Epub 2016 Jan 18.

Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.

Oncotarget. 2015 Sep 22;6(28):25588-601. doi: 10.18632/oncotarget.4436.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Potential therapeutic target for triple-negative breast cancer.

作者信息

Gilbert Judith A

出版信息

Lancet Oncol. 2012 Aug;13(8):e330. doi: 10.1016/s1470-2045(12)70298-x.

DOI:10.1016/s1470-2045(12)70298-x

PMID:23024992

Abstract

摘要

相似文献

Potential therapeutic target for triple-negative breast cancer.

Lancet Oncol. 2012 Aug;13(8):e330. doi: 10.1016/s1470-2045(12)70298-x.

Ribociclib in HR-positive, HER2-negative breast cancer.

Lancet Oncol. 2016 Nov;17(11):e482. doi: 10.1016/S1470-2045(16)30502-2. Epub 2016 Oct 13.

Breast density influences tumor subtypes and tumor aggressiveness.

J Natl Cancer Inst. 2011 Aug 3;103(15):1143-5. doi: 10.1093/jnci/djr263. Epub 2011 Jul 27.

Are triple-negative tumours and basal-like breast cancer synonymous?

Breast Cancer Res. 2007;9(6):404; author reply 405. doi: 10.1186/bcr1827.

Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows.

J Clin Oncol. 2019 Apr 10;37(11):862-866. doi: 10.1200/JCO.18.02433. Epub 2019 Feb 27.

What is the value of the 21 gene recurrence score in HER2-negative patients?

J Clin Oncol. 2010 Nov 1;28(31):e647; author reply e648. doi: 10.1200/JCO.2010.31.2280. Epub 2010 Sep 27.

Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy.

J BUON. 2013 Jan-Mar;18(1):289.

Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?

Hum Pathol. 2017 Apr;62:215-221. doi: 10.1016/j.humpath.2016.12.019. Epub 2016 Dec 30.

Measurement of erbB-2 oncoprotein in human breast cancers by ELISA.

Biochem Soc Trans. 1992 Feb;20(1):82S. doi: 10.1042/bst020082s.

[Modern pharmacological therapy of breast cancer].

Orv Hetil. 2012 Jan 15;153(2):56-65. doi: 10.1556/OH.2012.29257.

引用本文的文献

Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.

Mol Oncol. 2016 Jun;10(6):775-88. doi: 10.1016/j.molonc.2016.01.002. Epub 2016 Jan 18.

Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.

Oncotarget. 2015 Sep 22;6(28):25588-601. doi: 10.18632/oncotarget.4436.